Mutlay Sayan

1.3k total citations
86 papers, 879 citations indexed

About

Mutlay Sayan is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Mutlay Sayan has authored 86 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 29 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Mutlay Sayan's work include Breast Cancer Treatment Studies (19 papers), Prostate Cancer Treatment and Research (16 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Mutlay Sayan is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Prostate Cancer Treatment and Research (16 papers) and Prostate Cancer Diagnosis and Treatment (15 papers). Mutlay Sayan collaborates with scholars based in United States, Türkiye and Canada. Mutlay Sayan's co-authors include Brooke T. Mossman, Arti Shukla, Stacie L. Beuschel, Maximilian B. MacPherson, Joyce K. Thompson, Bruce G. Haffty, Jedd Hillegass, Salma K. Jabbour, Nisha Ohri and Harvey I. Pass and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Mutlay Sayan

73 papers receiving 871 citations

Peers

Countries citing papers authored by Mutlay Sayan

Since Specialization

Citations

This map shows the geographic impact of Mutlay Sayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutlay Sayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutlay Sayan more than expected).

Fields of papers citing papers by Mutlay Sayan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutlay Sayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutlay Sayan. The network helps show where Mutlay Sayan may publish in the future.

Co-authorship network of co-authors of Mutlay Sayan

This figure shows the co-authorship network connecting the top 25 collaborators of Mutlay Sayan. A scholar is included among the top collaborators of Mutlay Sayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutlay Sayan. Mutlay Sayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination Metastasis-Targeted External Beam Radiation Therapy With 177Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer 2025 ·Practical Radiation Oncology ·(unknown), (unknown), (unknown), (unknown), Richard J. Lee, Philip J. Saylor, Xin Gao, Shadi A. Esfahani, Pedram Heidari, Praful Ravi, Mutlay Sayan, Jason A. Efstathiou, Heather A. Jacene, Sophia C. Kamran, Thomas S.C. Ng	4
2	Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer 2025 ·Eurasian Journal of Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), David D. Yang, Shalini Moningi, Jonathan E. Leeman, Peter F. Orio, Paul L. Nguyen, Anthony V. D’Amico, Mutlay Sayan	1
3	Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial 2024 ·Cancer ·(unknown), Ming‐Hui Chen, Marian Loffredo, Elizabeth McMahon, Peter F. Orio, Paul L. Nguyen, Anthony V. D’Amico, Mutlay Sayan	1
4	Elective Pelvic Lymph Node Radiation Therapy and the Risk of Death in Patients With Unfavorable-Risk Prostate Cancer: A Postrandomization Analysis 2024 ·Journal of Clinical Oncology ·Mutlay Sayan, Ming‐Hui Chen, Marian Loffredo, Elizabeth McMahon, Shalini Moningi, Peter F. Orio, Paul L. Nguyen, Anthony V. D’Amico	3
5	Prostate Cancer Awareness in the Middle East: A Cross-Sectional International Study 2024 ·JCO Global Oncology ·Mutlay Sayan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Farzin Vahedi, (unknown), (unknown), Yousef M. Hawsawi, (unknown), (unknown), (unknown), (unknown), Layth Mula‐Hussain, Shalini Moningi, Peter F. Orio, Banu Atalar, (unknown)	5
6	Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations 2024 ·Cancers ·Mutlay Sayan, (unknown), Mahmut Akgül, (unknown), (unknown), (unknown), (unknown), (unknown), Shalini Moningi, Jonathan E. Leeman, Peter F. Orio, Paul L. Nguyen, Anthony V. D’Amico, (unknown)	4
7	Impact of CT Online Adaptive Radiotherapy on Acute Toxicity in Patients Undergoing Prostate Radiotherapy 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Li Zhu, Jeremy S. Bredfeldt, Yun Hang Hu, (unknown), M. Czerminska, Cindy Hancox, S R Friesen, (unknown), Sarah Quirk, (unknown), Anthony V. D’Amico, Mutlay Sayan, Eun‐Kyoung Kim, Kent W. Mouw, Martin T. King, (unknown), Jonathan E. Leeman	0
8	Radiation therapy for prostate cancer in Syrian refugees: facing the need for change 2023 ·Frontiers in Public Health ·(unknown), Sarah S. Kılıç, (unknown), (unknown), (unknown), Tuğçe Kütük, (unknown), Lara Hathout, Shalini Moningi, Peter F. Orio, Banu Atalar, Mutlay Sayan	6
9	Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy 2023 ·Frontiers in Oncology ·Mutlay Sayan, Lara Hathout, Sarah S. Kılıç, (unknown), (unknown), Natalie Hassell, (unknown), (unknown), (unknown), Shicha Kumar, (unknown), Richard L. Agag, Bruce G. Haffty, (unknown)	2
10	Prostate Cancer Awareness in the Middle East 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Mutlay Sayan, (unknown), Badereddin Mohamad Al–Ali, (unknown), Fatemeh Vahedi, (unknown), Waseem Abbas, Yousef M. Hawsawi, Nader Tajik, (unknown), (unknown), (unknown), Layth Mula‐Hussain, Shalini Moningi, Peter F. Orio, (unknown)	1
11	Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ 2021 ·Journal of Clinical Oncology ·Apar Gupta, Sachin R. Jhawar, Mutlay Sayan, Zeinab Abou Yehia, Bruce G. Haffty, James B. Yu, Shi‐Yi Wang	6
12	Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies 2020 ·JNCI Journal of the National Cancer Institute ·Salma K. Jabbour, Terence M. Williams, Mutlay Sayan, Eric D. Miller, Jaffer A. Ajani, Andrew C. Chang, (unknown), Wael El‐Rifai, Michael G. Haddock, David H. Ilson, (unknown), Charles A. Kunos, Steven H. Lin, Geoffrey Liu, Pataje G.S. Prasanna, Anil K. Rustgi, Rosemary Wong, Bhadrasain Vikram, Mansoor M. Ahmed	7
13	The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis 2020 ·Medicina ·(unknown), (unknown), Mutlay Sayan, Birsen Yücel, (unknown), (unknown), Irina Vergalasova, Ahmet Altun, Saadettin Kılıçkap, (unknown), Nuran Beşe	4
14	Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy 2020 ·Frontiers in Oncology ·Mutlay Sayan, (unknown), (unknown), (unknown), Teuta Zoto Mustafayev, Görkem Güngör, Banu Atalar, Enis Özyar	8
15	Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity 2019 ·Journal of Gastrointestinal Oncology ·(unknown), Matthew P. Deek, Sinae Kim, Mutlay Sayan, Alison Grann, Raquel Wagman, Usha Malhotra, Lara Hathout, Nrusingh C. Biswal, Yin Zhang, John Langenfeld, Timothy J. Kennedy, David A. August, Salma K. Jabbour	10
16	Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution 2019 ·Advances in Radiation Oncology ·Nikhil Yegya‐Raman, Joseph Aisner, Sinae Kim, Mutlay Sayan, (unknown), John Langenfeld, (unknown), Jyoti Malhotra, Salma K. Jabbour	4
17	Current Treatment Strategies in Malignant Pleural Mesothelioma with a Treatment Algorithm 2019 ·Advances in respiratory medicine ·Mutlay Sayan, (unknown), Apar Gupta, Nisha Ohri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tuğçe Kütük, (unknown), (unknown), Salma K. Jabbour, Banu Atalar	12
18	Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC 2018 ·Journal of Thoracic Oncology ·Nikhil Yegya‐Raman, Kyle Wang, Sinae Kim, Meral Reyhan, Matthew P. Deek, Mutlay Sayan, (unknown), (unknown), Jyoti Malhotra, Joseph Aisner, Lawrence B. Marks, Salma K. Jabbour	76
19	Curcumin: A Double Hit on Malignant Mesothelioma 2014 ·Cancer Prevention Research ·(unknown), Joyce K. Thompson, Maximilian B. MacPherson, Stacie L. Beuschel, (unknown), Mutlay Sayan, Arti Shukla	50
20	Extracellular Signal-Regulated Kinase 5 and Cyclic AMP Response Element Binding Protein Are Novel Pathways Inhibited by Vandetanib (ZD6474) and Doxorubicin in Mesotheliomas 2014 ·American Journal of Respiratory Cell and Molecular Biology ·Mutlay Sayan, Arti Shukla, Maximilian B. MacPherson, (unknown), Jedd Hillegass, Timothy N. Perkins, Joyce K. Thompson, Stacie L. Beuschel, (unknown), Brooke T. Mossman	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact